Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Commentary

Hypervirulent Klebsiella pneumoniae: a Call for Consensus Definition and International Collaboration

Sohei Harada, Yohei Doi
Daniel J. Diekema, Editor
Sohei Harada
aDepartment of Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yohei Doi
aDepartment of Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
bDepartment of Microbiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
cDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
dCenter for Innovative Antimicrobial Therapy, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J. Diekema
University of Iowa College of Medicine
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.00959-18
  • Article
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Hypervirulent Klebsiella pneumoniae strains have higher potential to cause more severe and disseminated infections than classic K. pneumoniae strains. While initially reported from East Asian countries, cases have now been identified worldwide, sometimes in conjunction with extensive drug resistance. In this issue of the Journal of Clinical Microbiology, T. A. Russo et al. (J Clin Microbiol 56:e00776-18, 2018, https://doi.org/10.1128/JCM.00776-18) validated the diagnostic accuracy of biomarkers that differentiate hypervirulent K. pneumoniae strains from classic strains. This represents a major step forward in building a consensus definition and designing international studies aimed at elucidating the global epidemiology, clinical features, and outcome of this important pathogen.

The views expressed in this Commentary do not necessarily reflect the views of the journal or of ASM.

TEXT

Klebsiella pneumoniae infections have mainly been observed among hospitalized or immunocompromised patients, but clinicians in Taiwan first recognized an increasing number of pyogenic K. pneumoniae infections in the 1980s occurring among community-residing individuals without apparent immunodeficiency other than diabetes mellitus or anatomical abnormalities in biliary tracts (1, 2). The most common presentation of such infections was liver abscess sometimes complicated by endophthalmitis and meningitis, but other invasive infections were also reported, including osteomyelitis and necrotizing fasciitis (3, 4). Fang and colleagues observed that most strains causing these pyogenic infections showed hypermucoviscosity when grown on agar plates and proposed the generation of viscous strings exceeding 5 mm between a colony and a loop as the diagnostic criterion, which is commonly referred to as the string test (5). These strains were much more resistant than classic K. pneumoniae to in vitro killing by serum or to phagocytosis by neutrophils and macrophages and caused liver abscess and meningitis in mice; they have thus been referred to as hypervirulent K. pneumoniae (hvKp) strains.

The first gene identified as contributing to the hypermucoviscous phenotype in the representative strain NTUH-K2044 was magA (mucoviscosity-associated gene A), which also conferred increased virulence in mouse models (5). magA was later found to be identical to the wzy gene in K1 (wzy_K1), which is part of the capsule biosynthesis operon of strains belonging to capsule serotype K1; therefore, serotype K1 was recognized as the primary serogroup causing hvKp infections in Taiwan (1, 6). These serotype K1 strains are relatively monophyletic, belong to clonal group 23 (CG23) predominated by sequence type 23 (ST23), and have since been reported frequently from East Asian countries besides Taiwan, including South Korea, China, and Japan (7–9).

In addition to wzy_K1, several virulence factors have been identified that characterize the hypermucoviscous and hypervirulent phenotype in serotype K1 strains. They include the rmpA (regulator of mucoid phenotype A) genes and various siderophore genes. The prototypical hypermucoviscous K1 strain NTUH-K2044 carries two rmpA plasmid-borne genes (prmpA and prmpA2) on the same large plasmid (pK2044) and another copy on the chromosomal integrative conjugative element (ICE) (10). Epidemiological comparison of the mucoviscous phenotype and rmpA carriage status among K. pneumoniae bacteremia strains in Taiwan has demonstrated significant correlation between them and additionally identified hypermucoviscous strains with rmpA in serotypes other than K1 (11). On the other hand, rmpA- and rmpA2-positive, nonhypermucoviscous strains and rmpA- and rmpA2-negative, hypermucoviscous strains have also been found, suggesting the presence of yet other factors involved in the expression of the hypermucoviscous phenotype (12). Siderophores are important virulence factors that scavenge scarce ferric iron from the environment. In K. pneumoniae, aerobactin (encoded by iuc genes), salmochelin (encoded by iro genes), and yersiniabactin (encoded by irp genes) are the representative siderophores. In the serotype K1 NTUH-K2044 strain, the iuc and iro genes are located on the same plasmid pK2044 as the prmpA and prmpA2 genes (13). Among them, the iuc genes appear to be critical in conferring accentuated virulence (14, 15). More recently, some non-K1 K. pneumoniae strains, such as K2-ST86 and K2-ST380, have also been reported to cause community-onset pyogenic infections (16, 17). These non-K1 hypervirulent strains are more clonally diverse than K1-ST23 strains but often carry pK2044-like plasmids encoding rmpA and iuc genes (13).

Until recently, hvKp strains had been relatively susceptible to commonly used antimicrobial agents, with only a few exceptions, including several strains producing extended-spectrum beta-lactamase (ESBL) (7). However, a hospital-based outbreak caused by a carbapenem-resistant, KPC-producing K. pneumoniae ST11 strain which had acquired a pK2044-like plasmid was recently reported from China (18). The strain was hypervirulent in vivo and in fact caused high mortality among the infected patients. ST11 is the most common sequence type among KPC-producing K. pneumoniae strains in China and is considered to be a classical opportunistic K. pneumoniae clonal lineage in terms of virulence. Conversely, hypervirulent, antimicrobial-susceptible ST23 strains have also acquired plasmids carrying blaKPC and become carbapenem resistant (19). Thus, convergence of hypervirulence and multidrug resistance in K. pneumoniae, through both acquisition of resistance genes by hypervirulent strains and through acquisition of virulence genes by multidrug-resistant strains, poses a consequential public health challenge (20).

In this issue of the Journal of Clinical Microbiology, T. A. Russo and colleagues set out to evaluate biomarkers that can accurately differentiate hvKp and classical K. pneumoniae (cKp) strains (21). To do so, they first identified two sets of strains. One set consisted of an hvKp-rich cohort of 85 clinical strains that caused pyogenic infection in otherwise healthy outpatients in Taiwan and the United States; 45 of these strains represented disseminated infections, including endophthalmitis and necrotizing fasciitis. The second set consisted of a cKp-rich cohort of 90 randomly selected bacteremia strains collected in the United States, Canada, and the United Kingdom, under the assumption that hvKp strains would be extremely rare if existent at all in these countries. As a result, 5 of the 10 virulence genes investigated (peg-344, a putative inner membrane transporter gene located on the same virulence plasmids [22], iroB, iucA, prmpA, and prmpA2) showed a diagnostic accuracy of >0.95 in predicting strains in the hvKp-rich cohort. In addition, siderophore levels of ≥30 μg/ml as measured by a quantitative assay had a diagnostic accuracy of 0.96. The hypervirulence of the strains meeting these criteria was corroborated extensively in a murine sepsis model. On the other hand, the other attributes which have been associated with hvKp, including the typical capsule types (K1, K2, K5, K20, K54, and K57) and the string test, had a lower diagnostic accuracy of 0.90 in predicting hvKp over cKp.

The findings of this study have multiple implications for investigations of hvKp. Owing to the lack of a consensus definition of hvKp, studies have so far used various criteria (e.g., specific capsule types or a positive string test, alone or in combination) to define these strains. Because of this, whether a strain defined as hvKp in one study would also qualify as such in another study has been unclear, which has made interpretation and comparison of data challenging. If we can reach a consensus definition of hvKp by incorporating genotypic or phenotypic biomarkers validated to achieve the high diagnostic accuracy in the present study, there will be multiple benefits to the research and clinical communities. First of all, the microbiological and clinical features of hvKp can be accumulated and compared across different geographical areas. Second, early identification of hvKp infections may inform clinicians, allowing them to conduct early and vigorous searches for disseminated infection sites and potentially consider longer antimicrobial therapy than with cKp infections. Clinical studies can be designed to determine whether such strategies can improve patient outcome. Third, improved definition of hvKp at the strain level will also facilitate investigation of the potential impact of these strains on hospitalized and immunocompromised patients. If hvKp is found to cause severe infections in these special populations, then infection control practices may need to be evaluated to possibly implement contact precautions of carriers based on virulence rather than resistance. Finally, departure from the string test, which is intuitive and has served us well but has now been shown to have less than optimal accuracy, will allow for more systematic investigations and identification of novel serotypes or clones of hvKp which may be circulating or may emerge in the future.

The study by Russo and colleagues also identifies areas for further research. While comprehensive detection of peg-344, iroB, iucA, prmpA, and prmpA2 is ideal, a typical clinical microbiology laboratory is not yet equipped to routinely perform such PCR-based tests. It is also not yet clear if detection of one of the five genes with high diagnostic accuracy suffices. These genes often exist on the same virulence plasmids, and thus detection of multiple genes may become redundant; but genetic changes like deletion may alter the utility of each gene as a biomarker, depending on which specific strains are prevalent locally. For example, the KPC-producing hvKp strain that caused the fatal outbreak in China possessed prmpA2 but not prmpA (18), and strains from China were not included in this study. Detection of more than one gene may be a prudent approach for this reason. The siderophore assay proposed in this work may be a reasonable substitute if the process can be simplified enough to be feasible in clinical laboratories, especially in areas of endemicity. Also, whether emerging hvKp serotypes and clones exert their virulent phenotypes through the same sets of virulence factors remains unknown. Similar studies in different epidemiological contexts would be highly useful to see if these results can be replicated.

In clinical practice, microbiologists and infectious disease physicians have always inferred virulence of a microorganism based on the species identification and acted accordingly. However, if the approach to therapy can be individualized based on the predicted virulence of the specific infecting strain, in addition to the species and antimicrobial susceptibility data, to optimize clinical outcome, there could be a significant impact on how we approach treatment of bacterial infections. The distinct clinical behavior of hvKp and cKp strains implies that K. pneumoniae may be an ideal pathogen to explore such an approach once we can come to a consensus on the definition of hypervirulence in K. pneumoniae. The present study sets the framework for this exciting possibility. Furthermore, having such a common definition would facilitate designing and conducting international studies aimed at elucidating the global epidemiology and clinical features of this emerging pathogen.

ACKNOWLEDGMENTS

We thank David Paterson for helpful discussion.

Y.D. was supported by research grants from the National Institutes of Health (grants R01AI104895, R21AI123747, and R21AI135522).

FOOTNOTES

    • Accepted manuscript posted online 27 June 2018.
  • Address correspondence to Yohei Doi, yod4{at}pitt.edu.
  • Citation Harada S, Doi Y. 2018. Hypervirulent Klebsiella pneumoniae: a call for consensus definition and international collaboration. J Clin Microbiol 56:e00959-18. https://doi.org/10.1128/JCM.00959-18.

  • For the article discussed, see https://doi.org/10.1128/JCM.00776-18.

REFERENCES

  1. 1.↵
    1. Fang CT,
    2. Lai SY,
    3. Yi WC,
    4. Hsueh PR,
    5. Liu KL,
    6. Chang SC
    . 2007. Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis 45:284–293. doi:10.1086/519262.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Ko WC,
    2. Paterson DL,
    3. Sagnimeni AJ,
    4. Hansen DS,
    5. Von Gottberg A,
    6. Mohapatra S,
    7. Casellas JM,
    8. Goossens H,
    9. Mulazimoglu L,
    10. Trenholme G,
    11. Klugman KP,
    12. McCormack JG,
    13. Yu VL
    . 2002. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 8:160–166. doi:10.3201/eid0802.010025.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Prokesch BC,
    2. TeKippe M,
    3. Kim J,
    4. Raj P,
    5. TeKippe EM,
    6. Greenberg DE
    . 2016. Primary osteomyelitis caused by hypervirulent Klebsiella pneumoniae. Lancet Infect Dis 16:e190–e195. doi:10.1016/S1473-3099(16)30021-4.
    OpenUrlCrossRef
  4. 4.↵
    1. Cheng NC,
    2. Yu YC,
    3. Tai HC,
    4. Hsueh PR,
    5. Chang SC,
    6. Lai SY,
    7. Yi WC,
    8. Fang CT
    . 2012. Recent trend of necrotizing fasciitis in Taiwan: focus on monomicrobial Klebsiella pneumoniae necrotizing fasciitis. Clin Infect Dis 55:930–939. doi:10.1093/cid/cis565.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Fang CT,
    2. Chuang YP,
    3. Shun CT,
    4. Chang SC,
    5. Wang JT
    . 2004. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med 199:697–705. doi:10.1084/jem.20030857.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Chuang YP,
    2. Fang CT,
    3. Lai SY,
    4. Chang SC,
    5. Wang JT
    . 2006. Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis 193:645–654. doi:10.1086/499968.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Zhang Y,
    2. Zhao C,
    3. Wang Q,
    4. Wang X,
    5. Chen H,
    6. Li H,
    7. Zhang F,
    8. Li S,
    9. Wang R,
    10. Wang H
    . 2016. High prevalence of hypervirulent Klebsiella pneumoniae infection in China: geographic distribution, clinical characteristics, and antimicrobial resistance. Antimicrob Agents Chemother 60:6115–6120. doi:10.1128/AAC.01127-16.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Chung DR,
    2. Lee HR,
    3. Lee SS,
    4. Kim SW,
    5. Chang HH,
    6. Jung SI,
    7. Oh MD,
    8. Ko KS,
    9. Kang CI,
    10. Peck KR,
    11. Song JH
    . 2008. Evidence for clonal dissemination of the serotype K1 Klebsiella pneumoniae strain causing invasive liver abscesses in Korea. J Clin Microbiol 46:4061–4063. doi:10.1128/JCM.01577-08.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Harada S,
    2. Ishii Y,
    3. Saga T,
    4. Aoki K,
    5. Tateda K
    . 20 March 2018. Molecular epidemiology of Klebsiella pneumoniae K1 and K2 isolates in Japan. Diagn Microbiol Infect Dis doi:10.1016/j.diagmicrobio.2018.03.010.
    OpenUrlCrossRef
  10. 10.↵
    1. Hsu CR,
    2. Lin TL,
    3. Chen YC,
    4. Chou HC,
    5. Wang JT
    . 2011. The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited. Microbiology 157:3446–3457. doi:10.1099/mic.0.050336-0.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Yu WL,
    2. Ko WC,
    3. Cheng KC,
    4. Lee HC,
    5. Ke DS,
    6. Lee CC,
    7. Fung CP,
    8. Chuang YC
    . 2006. Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan. Clin Infect Dis 42:1351–1358. doi:10.1086/503420.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Lee CH,
    2. Liu JW,
    3. Su LH,
    4. Chien CC,
    5. Li CC,
    6. Yang KD
    . 2010. Hypermucoviscosity associated with Klebsiella pneumoniae-mediated invasive syndrome: a prospective cross-sectional study in Taiwan. Int J Infect Dis 14:e688–92. doi:10.1016/j.ijid.2010.01.007.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Struve C,
    2. Roe CC,
    3. Stegger M,
    4. Stahlhut SG,
    5. Hansen DS,
    6. Engelthaler DM,
    7. Andersen PS,
    8. Driebe EM,
    9. Keim P,
    10. Krogfelt KA
    . 2015. Mapping the Evolution of Hypervirulent Klebsiella pneumoniae. mBio 6:e00630-15. doi:10.1128/mBio.00630-15.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Russo TA,
    2. Olson R,
    3. Macdonald U,
    4. Metzger D,
    5. Maltese LM,
    6. Drake EJ,
    7. Gulick AM
    . 2014. Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniae. Infect Immun 82:2356–2367. doi:10.1128/IAI.01667-13.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Russo TA,
    2. Olson R,
    3. MacDonald U,
    4. Beanan J,
    5. Davidson BA
    . 2015. Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo. Infect Immun 83:3325–3333. doi:10.1128/IAI.00430-15.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Decre D,
    2. Verdet C,
    3. Emirian A,
    4. Le Gourrierec T,
    5. Petit JC,
    6. Offenstadt G,
    7. Maury E,
    8. Brisse S,
    9. Arlet G
    . 2011. Emerging severe and fatal infections due to Klebsiella pneumoniae in two university hospitals in France. J Clin Microbiol 49:3012–3014. doi:10.1128/JCM.00676-11.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Zhang Y,
    2. Sun J,
    3. Mi C,
    4. Li W,
    5. Zhao S,
    6. Wang Q,
    7. Shi D,
    8. Liu L,
    9. Ding B,
    10. Chang YF,
    11. Guo H,
    12. Guo X,
    13. Li Q,
    14. Zhu Y
    . 2015. First report of two rapid-onset fatal infections caused by a newly emerging hypervirulent K. pneumoniae ST86 strain of serotype K2 in China. Front Microbiol 6:721. doi:10.3389/fmicb.2015.00721.
    OpenUrlCrossRef
  18. 18.↵
    1. Gu D,
    2. Dong N,
    3. Zheng Z,
    4. Lin D,
    5. Huang M,
    6. Wang L,
    7. Chan EW,
    8. Shu L,
    9. Yu J,
    10. Zhang R,
    11. Chen S
    . 2018. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis 18:37–46. doi:10.1016/S1473-3099(17)30489-9.
    OpenUrlCrossRef
  19. 19.↵
    1. Zhang R,
    2. Lin D,
    3. Chan EW,
    4. Gu D,
    5. Chen GX,
    6. Chen S
    . 2016. Emergence of carbapenem-resistant serotype K1 hypervirulent Klebsiella pneumoniae strains in China. Antimicrob Agents Chemother 60:709–711. doi:10.1128/AAC.02173-15.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Chen L,
    2. Kreiswirth BN
    . 2018. Convergence of carbapenem-resistance and hypervirulence in Klebsiella pneumoniae. Lancet Infect Dis 18:2–3. doi:10.1016/S1473-3099(17)30517-0.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Russo TA,
    2. Olson R,
    3. Fang C-T,
    4. Stoesser N,
    5. Miller M,
    6. Macdonald U,
    7. Hutson A,
    8. Barker JH,
    9. La Hoz RM,
    10. Johnson JR
    , for the Hypervirulent Klebsiella pneumoniae Investigator Group (HVKPIG). 2018. Identification of biomarkers for the differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J Clin Microbiol 56:e00776-18. doi:10.1128/JCM.00776-18.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Bulger J,
    2. MacDonald U,
    3. Olson R,
    4. Beanan J,
    5. Russo TA
    . 2017. Metabolite transporter PEG344 is required for full virulence of hypervirulent Klebsiella pneumoniae strain hvKP1 after pulmonary but not subcutaneous challenge. Infect Immun 85:e00093-17. doi:10.1128/IAI.00093-17.
    OpenUrlAbstract/FREE Full Text
  • Copyright © 2018 American Society for Microbiology.

All Rights Reserved.

PreviousNext
Back to top
Download PDF
Citation Tools
Hypervirulent Klebsiella pneumoniae: a Call for Consensus Definition and International Collaboration
Sohei Harada, Yohei Doi
Journal of Clinical Microbiology Aug 2018, 56 (9) e00959-18; DOI: 10.1128/JCM.00959-18

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Hypervirulent Klebsiella pneumoniae: a Call for Consensus Definition and International Collaboration
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Hypervirulent Klebsiella pneumoniae: a Call for Consensus Definition and International Collaboration
Sohei Harada, Yohei Doi
Journal of Clinical Microbiology Aug 2018, 56 (9) e00959-18; DOI: 10.1128/JCM.00959-18
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • TEXT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X